Medical research

Institute working to accelerate COVID-19 drug development

As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...

Diseases, Conditions, Syndromes

Ebola analysis finds virus hasn't become deadlier, yet

Research from The University of Manchester using cutting edge computer analysis reveals that despite mutating, Ebola hasn't evolved to become deadlier since the first outbreak 40 years ago.

Diseases, Conditions, Syndromes

Towards a safe and efficient SARS-coronavirus vaccine

Live attenuated (weakened) viral vaccines are considered safe so long as their "reversal" to a virulent (or disease-causing) virus is prevented. A study published on October 29th in PLOS Pathogens reports on how to rationally ...

HIV & AIDS

UNL team explores new approach to HIV vaccine

Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.